OCULAR THERAPEUTIX INC's ticker is OCUL and the CUSIP is 67576A100. A total of 131 filers reported holding OCULAR THERAPEUTIX INC in Q1 2022. The put-call ratio across all filers is 1.09 and the average weighting 0.9%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2023 | $106,164 | -40.2% | 20,145 | -68.1% | 0.00% | -42.9% |
| Q4 2022 | $177,525 | -64.1% | 63,176 | -47.0% | 0.01% | -58.8% |
| Q3 2022 | $495,000 | +489.3% | 119,265 | +603.8% | 0.02% | +466.7% |
| Q1 2022 | $84,000 | -71.0% | 16,945 | -59.2% | 0.00% | -72.7% |
| Q4 2021 | $290,000 | -19.7% | 41,541 | +15.0% | 0.01% | -15.4% |
| Q3 2021 | $361,000 | -57.5% | 36,107 | -30.2% | 0.01% | -50.0% |
| Q1 2021 | $849,000 | – | 51,726 | – | 0.03% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| SUMMER ROAD LLC | 6,122,089 | $32,263 | 100.00% |
| Opaleye Management Inc. | 6,105,900 | $32,178,093 | 9.64% |
| DELTEC ASSET MANAGEMENT LLC | 1,913,612 | $10,084,735 | 2.49% |
| Knoll Capital Management, LLC | 200,000 | $1,504,000 | 2.32% |
| Endurant Capital Management LP | 512,744 | $2,702,161 | 1.39% |
| Knoll Capital Management, LLC | 95,800 | $504,866 | 0.78% |
| Covestor Ltd | 60,008 | $316 | 0.28% |
| Ikarian Capital, LLC | 200,000 | $1,054,000 | 0.24% |
| EAM Investors, LLC | 224,211 | $1,181,592 | 0.23% |
| Nebula Research & Development LLC | 22,474 | $118,438 | 0.21% |